46. Malignant rheumatoid arthritis Clinical trials / Disease details


Clinical trials : 4,325 Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00491933
(ClinicalTrials.gov)
June 200725/6/2007Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFa AntagonistsComparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFa AntagonistsRheumatoid Arthritis;Spondylarthritis;TuberculosisProcedure: Quantiferon-TB Gold assay;Procedure: Tuberculin skin testOspedale L. Sacco – Polo UniversitarioNULLRecruiting18 Years80 YearsBoth100N/AItaly